Title : mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.

Pub. Date : 2009 Sep 1

PMID : 19690197






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
2 mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
3 Increased expression of phospho-mTOR was observed in cisplatin-resistant RMG1-CR and KOC7C-CR cells, compared with the respective parental cells. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
4 This increased expression of phospho-mTOR in cisplatin-resistant cells was associated with increased activation of AKT. Cisplatin mechanistic target of rapamycin kinase Homo sapiens
5 Moreover, mTOR inhibition by RAD001 may be efficacious as a second-line treatment of recurrent disease in patients previously treated with cisplatin. Cisplatin mechanistic target of rapamycin kinase Homo sapiens